QUOTE AND NEWS
Reuters  Sep 20  Comment 
Pfizer Inc said it will acquire Icagen Inc through a second-step merger as it now has sufficient voting power in the target.
StreetInsider.com  Sep 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pfizer+%28PFE%29+Subsequent+Tender+Offer+for+Icagen+%28ICGN%29+Expires/6797987.html for the full story.
Reuters  Sep 16  Comment 
Pfizer Inc reported an increased stake in Icagen Inc, four days after announcing that it had extended its tender offer to buy the biotech firm for a final time.
Mondo Visione  Sep 14  Comment 
Ladies and Gentlemen, Dear friends, I am delighted to open this panel on the Future of Financial Regulation in front of such a prestigious assembly and especially since  the  International  Corporate  Governance  Network  Annual...
Reuters  Sep 13  Comment 
Pfizer Inc said it was extending its tender offer for Icagen Inc for the final time till September 19 -- its third extension since Icagen asked its shareholders to accept the deal.
Reuters  Sep 2  Comment 
Pfizer Inc extended the expiration date of its tender offer for Icagen Inc. until tonight 6 p.m. EDT.
Reuters  Sep 1  Comment 
Pfizer Inc said it extended its tender offer for Icagen Inc by 24 hours, to midnight Eastern Time Thursday.
Reuters  Aug 29  Comment 
Icagen Inc on Monday urged its shareholders to accept a $6 per share offer from Pfizer Inc after the world's biggest drugmaker said last week that it would not raise its offer.
Globe Newswire  Aug 29  Comment 
RESEARCH TRIANGLE PARK, N.C., Aug. 29, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has sent the following letter to stockholders affirming the Board's recommendation after receiving a letter from Pfizer Inc. (NYSE:PFE)
Reuters  Aug 26  Comment 
Pfizer Inc has informed Icagen's board that its best and final offer price for the biopharmaceutical company was $6 a share and that it would not pay more.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki